Ten-year outcomes of whole-pelvic intensity-modulated radiation therapy for prostate cancer with regional lymph node metastasis.

Kiyonao NakamuraYoshiki NorihisaItaru IkedaHaruo InokuchiRihito AizawaToshiyuki KamotoTomomi KambaTakahiro InoueToshinari YamasakiShusuke AkamatsuTakashi KobayashiOsamu OgawaTakashi Mizowaki

Published in: Cancer medicine (2022)

WP SIB-IMRT can be safely administered to patients with pelvic node-positive prostate cancer. Since grade group 5 and detectable nadir PSA levels are risks for castration resistance, we may need to increase the intensity of treatment for such cases.

Keyphrases

prostate cancer
lymph node metastasis
radical prostatectomy
rectal cancer
squamous cell carcinoma
papillary thyroid
lymph node
type diabetes
risk assessment
metabolic syndrome
smoking cessation